Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In-house dual CAR T-cell therapy development for multiple myeloma
NL-OMON56725Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2024
- Countries
- 1
01
Overview
Open-label trial in multiple myeloma (MM) (5 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Effective production of CAR T-cells from patient blood, Group-level manufacturing success and 1 more. Started Aug 2024; status: completed.
02
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NL-OMON56725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56725.